A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection

BACKGROUND: A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabrine (TDF-FTC) can reduce HIV acquisition among men who have sex with men (MSM) and transgender (TG) women by 44%, and up to 90% if taken daily. We explored how medical and service provider...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Emily A., Hazelton, Patrick, Lane, Tim, Christopoulos, Katerina A., Galindo, Gabriel R., Steward, Wayne T., Morin, Stephen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394704/
https://www.ncbi.nlm.nih.gov/pubmed/22792384
http://dx.doi.org/10.1371/journal.pone.0040603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394704/
https://www.ncbi.nlm.nih.gov/pubmed/22792384
http://dx.doi.org/10.1371/journal.pone.0040603

Ejemplares similares